Reported Aug 27, 2014 · Terminated
Wockhardt Metoprolol Succinate Extended-Release Tablets, USP 200 mg, a) 100-count bottle (NDC 64679-737-02), b)…
Wockhardt USA Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Wockhardt Usa Inc. · 20 Waterview Blvd., Suite 3 · Parsippany, NJ · 07054
Is this the product you have?
- Wockhardt Metoprolol Succinate Extended-Release Tablets, USP 200 mg, a) 100-count bottle (NDC 64679-737-02), b) 500-count bottle (NDC 64679-737-03) Rx only
- Manufactured byWockhardt Limited Mumbai
- India Distributed byWockhardt USA LLC 20 Waterview Boulevard. Parsippany, NJ 07054 USA
- Lot codes and dates
Lot # a) LN11005Exp 04/15LN11006Exp 04/15b) LN10979Exp. 04/15LN10980Exp. 04/15
- Amount recalled
- 11,661 HDPE bottles
Where it was sold
- Nationwide
Why it was recalled
Failed Dissolution Specifications: Dissolution failures found during testing of control samples at the four hour time point.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Wockhardt USA Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.